The Ras-ERK pathway is required for the induction of neuronal nitric oxide synthase in differentiating PC12 cells

Christopher M. Schonhoff, Dylan A. Bulseco, Deborah M. Brancho, Luis F. Parada, Alonzo H. Ross

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

We have studied the role of MAP kinase pathways in neuronal nitric oxide synthase (nNOS) induction during the differentiation of PC12 cells. In nerve growth factor (NGF)-treated PC12 cells, we find nNOS induced at RNA and protein levels, resulting in increased NOS activity. We note that neither nNOS mRNA, nNOS protein nor NOS activity is induced by NGF treatment in cells that have been infected with a dominant negative Ras adenovirus. We have also used drugs that block MAP kinase pathways and assessed their ability to inhibit nNOS induction. Even though U0126 and PD98059 are both MEK inhibitors, we find that U0126, but not PD98059, blocks induction of nNOS protein and NOS activity in NGF-treated PC12 cells. Also, the p38 kinase inhibitor, SB203580, does not block nNOS induction in our clone of PC12 cells. Since the JNK pathway is not activated in NGF-treated PC12 cells, we conclude that the Ras-ERK pathway and not the p38 or JNK pathway is required for nNOS induction in NGF-treated PC12 cells. We find that U0126 is much more effective than PD98059 in blocking the Ras-ERK pathway, thereby explaining the discrepancy in nNOS inhibition. We conclude that the Ras-ERK pathway is required for nNOS induction.

Original languageEnglish (US)
Pages (from-to)631-639
Number of pages9
JournalJournal of Neurochemistry
Volume78
Issue number3
DOIs
StatePublished - 2001

Fingerprint

Nitric Oxide Synthase Type I
MAP Kinase Signaling System
PC12 Cells
Nerve Growth Factor
Phosphotransferases
Proteins
Mitogen-Activated Protein Kinase Kinases
Adenoviridae
Clone Cells
RNA

Keywords

  • MAP kinase
  • Nerve growth factor
  • Nitric oxide
  • p38 kinase
  • Pheochromocytoma
  • Signal transduction

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

The Ras-ERK pathway is required for the induction of neuronal nitric oxide synthase in differentiating PC12 cells. / Schonhoff, Christopher M.; Bulseco, Dylan A.; Brancho, Deborah M.; Parada, Luis F.; Ross, Alonzo H.

In: Journal of Neurochemistry, Vol. 78, No. 3, 2001, p. 631-639.

Research output: Contribution to journalArticle

Schonhoff, Christopher M. ; Bulseco, Dylan A. ; Brancho, Deborah M. ; Parada, Luis F. ; Ross, Alonzo H. / The Ras-ERK pathway is required for the induction of neuronal nitric oxide synthase in differentiating PC12 cells. In: Journal of Neurochemistry. 2001 ; Vol. 78, No. 3. pp. 631-639.
@article{6bca77efea5b422ba5725fcbaf8b9a2f,
title = "The Ras-ERK pathway is required for the induction of neuronal nitric oxide synthase in differentiating PC12 cells",
abstract = "We have studied the role of MAP kinase pathways in neuronal nitric oxide synthase (nNOS) induction during the differentiation of PC12 cells. In nerve growth factor (NGF)-treated PC12 cells, we find nNOS induced at RNA and protein levels, resulting in increased NOS activity. We note that neither nNOS mRNA, nNOS protein nor NOS activity is induced by NGF treatment in cells that have been infected with a dominant negative Ras adenovirus. We have also used drugs that block MAP kinase pathways and assessed their ability to inhibit nNOS induction. Even though U0126 and PD98059 are both MEK inhibitors, we find that U0126, but not PD98059, blocks induction of nNOS protein and NOS activity in NGF-treated PC12 cells. Also, the p38 kinase inhibitor, SB203580, does not block nNOS induction in our clone of PC12 cells. Since the JNK pathway is not activated in NGF-treated PC12 cells, we conclude that the Ras-ERK pathway and not the p38 or JNK pathway is required for nNOS induction in NGF-treated PC12 cells. We find that U0126 is much more effective than PD98059 in blocking the Ras-ERK pathway, thereby explaining the discrepancy in nNOS inhibition. We conclude that the Ras-ERK pathway is required for nNOS induction.",
keywords = "MAP kinase, Nerve growth factor, Nitric oxide, p38 kinase, Pheochromocytoma, Signal transduction",
author = "Schonhoff, {Christopher M.} and Bulseco, {Dylan A.} and Brancho, {Deborah M.} and Parada, {Luis F.} and Ross, {Alonzo H.}",
year = "2001",
doi = "10.1046/j.1471-4159.2001.00432.x",
language = "English (US)",
volume = "78",
pages = "631--639",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - The Ras-ERK pathway is required for the induction of neuronal nitric oxide synthase in differentiating PC12 cells

AU - Schonhoff, Christopher M.

AU - Bulseco, Dylan A.

AU - Brancho, Deborah M.

AU - Parada, Luis F.

AU - Ross, Alonzo H.

PY - 2001

Y1 - 2001

N2 - We have studied the role of MAP kinase pathways in neuronal nitric oxide synthase (nNOS) induction during the differentiation of PC12 cells. In nerve growth factor (NGF)-treated PC12 cells, we find nNOS induced at RNA and protein levels, resulting in increased NOS activity. We note that neither nNOS mRNA, nNOS protein nor NOS activity is induced by NGF treatment in cells that have been infected with a dominant negative Ras adenovirus. We have also used drugs that block MAP kinase pathways and assessed their ability to inhibit nNOS induction. Even though U0126 and PD98059 are both MEK inhibitors, we find that U0126, but not PD98059, blocks induction of nNOS protein and NOS activity in NGF-treated PC12 cells. Also, the p38 kinase inhibitor, SB203580, does not block nNOS induction in our clone of PC12 cells. Since the JNK pathway is not activated in NGF-treated PC12 cells, we conclude that the Ras-ERK pathway and not the p38 or JNK pathway is required for nNOS induction in NGF-treated PC12 cells. We find that U0126 is much more effective than PD98059 in blocking the Ras-ERK pathway, thereby explaining the discrepancy in nNOS inhibition. We conclude that the Ras-ERK pathway is required for nNOS induction.

AB - We have studied the role of MAP kinase pathways in neuronal nitric oxide synthase (nNOS) induction during the differentiation of PC12 cells. In nerve growth factor (NGF)-treated PC12 cells, we find nNOS induced at RNA and protein levels, resulting in increased NOS activity. We note that neither nNOS mRNA, nNOS protein nor NOS activity is induced by NGF treatment in cells that have been infected with a dominant negative Ras adenovirus. We have also used drugs that block MAP kinase pathways and assessed their ability to inhibit nNOS induction. Even though U0126 and PD98059 are both MEK inhibitors, we find that U0126, but not PD98059, blocks induction of nNOS protein and NOS activity in NGF-treated PC12 cells. Also, the p38 kinase inhibitor, SB203580, does not block nNOS induction in our clone of PC12 cells. Since the JNK pathway is not activated in NGF-treated PC12 cells, we conclude that the Ras-ERK pathway and not the p38 or JNK pathway is required for nNOS induction in NGF-treated PC12 cells. We find that U0126 is much more effective than PD98059 in blocking the Ras-ERK pathway, thereby explaining the discrepancy in nNOS inhibition. We conclude that the Ras-ERK pathway is required for nNOS induction.

KW - MAP kinase

KW - Nerve growth factor

KW - Nitric oxide

KW - p38 kinase

KW - Pheochromocytoma

KW - Signal transduction

UR - http://www.scopus.com/inward/record.url?scp=0034899731&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034899731&partnerID=8YFLogxK

U2 - 10.1046/j.1471-4159.2001.00432.x

DO - 10.1046/j.1471-4159.2001.00432.x

M3 - Article

C2 - 11483666

AN - SCOPUS:0034899731

VL - 78

SP - 631

EP - 639

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 3

ER -